Focused ultrasound treatment can be a shit for the symptoms of uterine fibroids and could limit the pressure on the subsequent processes of at least two years, according to a study published in the edition of August 1 amp the journal Obstetrics, Gynecology, Reuters Health reports (Reuters Health, 8 / 6). Uterine fibroids, which are noncancerous uterine tumors, can result in pain, miscarriage, and lead to prolonged and heavy menstrual periods (Kaiser Daily Women's Force Program Report 3 / 7). For reflection, Elizabeth Stewart, of the Mayo Clinic and his colleagues treated 359 women in a total of four clinical trials rare between 2002 and 2006. Participants were followed someone they are a regular two to three years. The researchers acclimated to the form of focused ultrasound to make the arrest fibroids resonance imaging guidance. According to Reuters health, the technique involves focusing ultrasound unit in an area roughly the size of a jelly under the guidance of MRI. RM then presents a picture of the dimensions of the heating to the target cell is destroyed and the adjacent healthy tissue is protected, according to Reuters Health. The researchers said that all women who underwent the relevant intelligent treatment decreases the severity of the symptoms of fibroids three months after the approximation. It was observed that treatment efficacy depends on the extent to which the fibroid was deprived of its blood supply. According to investigators, most of this volume is not perfused, the results of reducing the severity of the syndrome were. Participants with low nonperfused volumes were significantly more likely to require additional treatment during followup of the time, the study said. It was reported that 13% of women refers to any additional treatment required within two years (Haleness Reuters, 8 / 6). br Reaction According to the New York Times, neither the study nor an interview with Stewart was a clear answer to the question of how much sustained relief is offered by the procedure. We all want to know the longterm efficacy of focused ultrasound, "Stewart said. He added, quot; The problem we had to deal with in this study is that patients treated with the treatment they were receiving very different from those treated later. William Parker, director of the nonprofit organization of treatment, he said, much of the data one would expect in this type of study is not adding as a doctor, this doesn't help me. Carla Dionne, NUFF executive director, also said that the presentation of data in the study was incomplete. He added that concerns the study did not provide detailed information on the possible adverse effects such as burns and nerve damage. The study was funded by InSightec, a company based in Israel, which makes the treatment team. According to the Times, all data on treatment outcomes have been generated by clinical trials financed by InSightec. There are no studies available that compare focused ultrasound with other fibroid therapies or with placebos or, the Times reports (Rabin, New York Times, 8 / 7). br www.kaisernetwork.org Reprinted with permission. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at www.kaisernetwork.org / dailyreports / healthpolicy. The Journal of the Kaiser Health Policy Report is published for kaisernetwork.org, a free service of The J. Henry Kaiser Family Foundation. 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved. br br
